Loading…
Loading…
if we could get a little bit more color on the Opsilura in PN and why the FDA was asking for another phase three
Can you maybe just comment to some of the intra-quarter dynamics there that you saw from the JAK going into effect
pretty good beat this quarter. Just curious if you can maybe comment on just some of the dynamics with the fourteen million dollars of sales